January 13, 2014 Esperion Therapeutics Announces the Appointment of Antonio M. Gotto Jr., M.D., DPhil, as Director PLYMOUTH, Mich.--(BUSINESS WIRE)-- Esperion Therapeutics, Inc. (Nasdaq: ESPR), a clinical-stage biopharm

First Page		Document Content
Date: 2014-01-13 12:24:20		January 13, 2014 Esperion Therapeutics Announces the Appointment of Antonio M. Gotto Jr., M.D., DPhil, as Director PLYMOUTH, Mich.--(BUSINESS WIRE)-- Esperion Therapeutics, Inc. (Nasdaq: ESPR), a clinical-stage biopharm Add to Reading List Source URL: www.arboretumvc.com Download Document from Source Website File Size: 19,15 KB Share Document on Facebook